Press Releases - Kerecis

Fish-Skin Company Kerecis Announces MariGen Micro™

Kerecis Communications June 2, 2021 No Comments

The easy-to-use fish-skin graft fills a void as wound-treatment companies withdraw human-derived products per FDA guidance Arlington, VA and Reykjavik, Iceland – June 2, 2021 – Kerecis, the company pioneering the…

Kerecis Introduces Omega3 GraftGuide Fish Skin to Help Burn Victims Heal

Kerecis Communications April 20, 2021 No Comments

Large, mesh fish-skin grafts from Iceland can bring relief to patients and help them regain active lives WAILEA, HAWAII, and REYKJAVIK, ICELAND — April 20, 2021 — Kerecis®, the company…

U.S. Army Institute of Surgical Research Demonstrates Superior Results of Kerecis Omega3 Burn

Kerecis Communications March 12, 2021 No Comments

Peer-reviewed study shows large, severe burns heal faster when treated with Kerecis fish skin ARLINGTON, VIRGINIA, and REYKJAVIK, ICELAND—March 12, 2021—Researchers from the U.S. Army Institute of Surgical Research have…

Kerecis CFO Mike Cadigan (L) and CEO G. Fertram Sigurjonsson

Medical-Fish-Skin Company Kerecis Names Mike Cadigan CFO

Kerecis Communications January 21, 2021 No Comments

NEW FINANCIAL LEADERSHIP FOR FASTEST GROWING COMPANY IN U.S. REGENERATIVE-TISSUE MARKET ARLINGTON, VA, and REYKJAVIK, ICELAND — January 21, 2020 — Kerecis, the fastest growing company in the regenerative-tissue market…

Medical-Fish-Skin Company Kerecis the Fastest Growing Company in the U.S. Regenerative-Tissue Market

Kerecis Communications December 22, 2020 No Comments

Sales and market share more than double ARLINGTON, VA and REYKJAVIK, ICELAND — December 22, 2020 — Kerecis is the fastest growing company in the regenerative-tissue market in the United…

Melling Medical and Kerecis Deliver Cutting-Edge Fish Skin Wound Care to America’s Veterans

Kerecis Communications October 27, 2020 No Comments

Purchase agreement provides pioneering cellular therapy technology to the VHA ALEXANDRIA, Va. and ARLINGTON, Va., Oct. 27, 2020 /PRNewswire/ — MellingMedical has signed a Wound Care Blanket Purchase Agreement (BPA), which will provide the Kerecis fish-skin,…

Kerecis to Donate FDA-Approved Fish Skin for Burn Victims of West Coast Fires

Kerecis Communications September 14, 2020 No Comments

Arlington, VA and Reykjavik, Iceland—September 14, 2020—Kerecis®, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, is donating its Kerecis Omega3 Burn product…

Medical Fish Skin Company Kerecis Again Named Iceland’s Fastest Growing Company

Kerecis Communications August 28, 2020 No Comments

Reykjavik, Iceland — August 28, 2020 — The Icelandic Growth Consortium today named Kerecis the country’s fastest growing company. For the four past years Kerecis has either been the fastest…

Medical Fish Skin Company Kerecis Secures USD 21 Million Financing

Kerecis Communications August 27, 2020 No Comments

A Silicon Valley Bank credit facility and additional financing from other lenders increase operational flexibility and support the company’s long-term strategy Arlington, VA and Reykjavik, Iceland — August 27, 2020…

Kerecis Educational Webinars Focus on Omega3 Rich Fish Skin for Wound Care

Kerecis Communications May 26, 2020 No Comments

Arlington, VA — Kerecis, the company pioneering the use of fish skin and fatty acids in tissue regeneration and tissue protection, will present three educational lectures on wound care in…

Medical Fish Skin Company Kerecis to Release a Telemedicine App, Providing Access to Product Advice

Kerecis Communications April 15, 2020 No Comments

Arlington, VA — April 15, 2020 — The new Kerecis telemedicine service, TeleKer™, enables healthcare providers to get timely, personalized advice on how to treat wounds with Kerecis products. Healthcare…

Kerecis Begins Omega3 Viruxide COVID-19 Trial at the National Hospital of Iceland

Kerecis Communications April 9, 2020 No Comments

Kerecis and the National Hospital of Iceland are conducting a randomized, controlled, double-blind clinical study to evaluate the effectiveness of the Kerecis Omega3 Viruxide system on COVID-19 patients. The trial…

Peer-Reviewed Article in “Wounds” Examines Efficacy of Kerecis Fish Skin Treatment for Diabetic Foot Wounds

Kerecis Communications November 6, 2019 No Comments

The 58 patient study shows 87.57 percent mean reduction of wound sizes ARLINGTON, Va.–The efficacy of the Kerecis fish skin treatment for diabetic lower-extremity wounds is discussed in a new…

G. Fertram Sigurjonsson and Mr. Olafur Ragnar Grimsson

Former President of Iceland Joins the Board of Kerecis, the Medical Fish Skin Company

Kerecis Communications August 5, 2019 No Comments

Arlington, VA and Reykjavik, Iceland – August 5, 2019 — Olafur Ragnar Grimsson, who was the President of Iceland for 20 years, has joined the board of Kerecis Limited. Kerecis…

Medical Fish Skin Company Kerecis Limited Completes $16 Million Series C Offering

Kerecis Communications June 13, 2019 No Comments

Arlington, VA and Reykjavik, Iceland – June 12, 2019 — Kerecis Limited, the company pioneering the use of fish skin in tissue regeneration, has completed a $16 million Series C…

Category: Press Releases

Fish-Skin Company Kerecis Announces MariGen Micro™

Kerecis Introduces Omega3 GraftGuide Fish Skin to Help Burn Victims Heal

U.S. Army Institute of Surgical Research Demonstrates Superior Results of Kerecis Omega3 Burn

Medical-Fish-Skin Company Kerecis Names Mike Cadigan CFO

Medical-Fish-Skin Company Kerecis the Fastest Growing Company in the U.S. Regenerative-Tissue Market

Melling Medical and Kerecis Deliver Cutting-Edge Fish Skin Wound Care to America’s Veterans

Kerecis to Donate FDA-Approved Fish Skin for Burn Victims of West Coast Fires

Medical Fish Skin Company Kerecis Again Named Iceland’s Fastest Growing Company

Medical Fish Skin Company Kerecis Secures USD 21 Million Financing

Kerecis Educational Webinars Focus on Omega3 Rich Fish Skin for Wound Care

Medical Fish Skin Company Kerecis to Release a Telemedicine App, Providing Access to Product Advice

Kerecis Begins Omega3 Viruxide COVID-19 Trial at the National Hospital of Iceland

Peer-Reviewed Article in “Wounds” Examines Efficacy of Kerecis Fish Skin Treatment for Diabetic Foot Wounds

Former President of Iceland Joins the Board of Kerecis, the Medical Fish Skin Company

Medical Fish Skin Company Kerecis Limited Completes $16 Million Series C Offering

Products